Results 171 to 180 of about 4,064 (194)

CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status

Journal of Infection, 2019
Clinical application of the CD8 response as measured by the newer interferon gamma release assay, QuantiFERON-TB Gold-Plus (QFT-Plus), remains to be investigated.We performed this prospective study and recruited active TB patients, contacts with latent tuberculosis infection (LTBI) and contacts without LTBI in two centres in northern Taiwan in 2017 ...
Meng-Rui, Lee, Chia-Hao, Chang, Lih-Yu, Chang, Yu-Chung, Chuang, Hsin-Yun, Sun, Jann-Tay, Wang, Jann-Yuan, Wang   +6 more
openaire   +2 more sources

IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection

Journal of Infection and Chemotherapy, 2021
The new-generation QuantiFERON (QFT)-TB Gold Plus (QFT-Plus) is expected to be useful because it includes a new peptide that is supposed to induce a CD8+ T cell response. There is a need for a new marker with sensitivity higher than that of the conventional IFN-γ release assays owing to false-negative results in the latter.
Shunsuke Akashi, Maho Suzukawa, Keita Takeda, Isao Asari, Masahiro Kawashima, Nobuharu Ohshima, Eri Inoue, Ryota Sato, Masahiro Shimada, Junko Suzuki, Akira Yamane, Atsuhisa Tamura, Ken Ohta, Shigeto Tohma, Katsuji Teruya, Hideaki Nagai   +15 more
openaire   +2 more sources

Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan

Journal of Infection and Chemotherapy, 2018
The QuantiFERON-TB Gold Plus (QFT-Plus) was introduced in 2015 as a new generation of interferon-gamma release assays (IGRAs) designed to detect Mycobacterium tuberculosis infection (TB). Examination of its diagnostic accuracy is crucial before it is launched in Japan.We examined 99 patients with laboratory-confirmed active TB (patients) and 117 ...
Jin Takasaki, Toshie Manabe, Eriko Morino, Yoshikazu Muto, Masao Hashimoto, Motoyasu Iikura, Shinyu Izumi, Haruhito Sugiyama, Koichiro Kudo   +8 more
openaire   +2 more sources

Serial testing of Mycobacterium tuberculosis infection in Chinese village doctors by QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold in-Tube and T-SPOT.TB

Journal of Infection, 2019
To evaluate the performance of QuantiFERON-TB Gold Plus (QFT-Plus) on Mycobacterium tuberculosis (MTB) infection test among registered village doctors from China.MTB infection of the registered village doctors in Zhongmu County were tested using QFT-Plus and two other interferon-gamma release assays (IGRAs) in parallel: QuantiFERON-TB Gold In-Tube (QFT)
Haoran, Zhang, Henan, Xin, Dakuan, Wang, Shouguo, Pan, Zisen, Liu, Xuefang, Cao, Jinxing, Wang, Xiangwei, Li, Boxuan, Feng, Mufei, Li, Qianting, Yang, Mingxia, Zhang, Qi, Jin, Lei, Gao   +13 more
openaire   +2 more sources

QuantiFERON-TB Gold Plus: can we stop at three?

Pathology, 2023
Yuan Yi Constance Chen, Partha Pratim De
openaire   +1 more source

Blood Collection Technique May Affect QuantiFERON-TB Gold Plus Assay Results

Annals of the American Thoracic Society, 2019
Saroochi Agarwal, Duc T. Nguyen, Justin D. Lew, Edward A. Graviss   +3 more
openaire   +2 more sources

Clinical evaluation of QuantiFERON®-TB Gold Plus directly compared with QuantiFERON®-TB Gold In-Tube and T-Spot®.TB for active pulmonary tuberculosis in the elderly

Journal of Infection and Chemotherapy, 2021
Kazumasa Akagi, Takahiro Takazono, Noriho Sakamoto   +2 more
exaly  

QuantiFERON-TB GOLD PLUS indéterminé : quels facteurs prédictifs ?

La Revue de Médecine Interne
Z. Hamza, A. Jerbi, L. Chtourou, H. Hachicha, R. Akrout, M.W. Ben, A.F. Ben, N. Tahri, H. Masmoudi, S. Feki   +9 more
openaire   +1 more source

W071 Investigation of serial tests of quantiferon-tb gold in-tube and quantiferon-tb gold-plus in contacts to patients with active tuberculosis

Clinica Chimica Acta, 2022
S. Yoon, H. Moon, A. Yi, H. Kim, H. Chung, M. Hur, Y. Yun, G.H. Yoo   +7 more
openaire   +1 more source

Comparison of the QuantiFERON-TB® Gold Plus on LIAISON® XL and T-SPOT.TB for the diagnosis of latent Mycobacterium tuberculosis infection in a low tuberculosis incidence population

Diagnostic Microbiology and Infectious Disease, 2022
Laura Heireman, Dieter Geysels, Emmanuel André   +2 more
exaly